Letter to editor on "Efficacy and safety of immunotherapy-based neoadjuvant regimens in locally advanced gastric cancer: a meta-analysis based on high-quality clinical trials"
机构：[1]Department of Gastroenterology, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China.[2]Department of Pharmacy, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China.[3]Department of Ultrasound, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China.
第一作者机构：[1]Department of Gastroenterology, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Mou Yaning,Xu Yu,Hu Xuanfan.Letter to editor on "Efficacy and safety of immunotherapy-based neoadjuvant regimens in locally advanced gastric cancer: a meta-analysis based on high-quality clinical trials"[J].International Journal Of Surgery (London, England).2025,doi:10.1097/JS9.0000000000003006.
APA：
Mou Yaning,Xu Yu&Hu Xuanfan.(2025).Letter to editor on "Efficacy and safety of immunotherapy-based neoadjuvant regimens in locally advanced gastric cancer: a meta-analysis based on high-quality clinical trials".International Journal Of Surgery (London, England),,
MLA：
Mou Yaning,et al."Letter to editor on "Efficacy and safety of immunotherapy-based neoadjuvant regimens in locally advanced gastric cancer: a meta-analysis based on high-quality clinical trials"".International Journal Of Surgery (London, England) .(2025)
